Literature DB >> 6361233

Neuroendocrine responses to stimulation of the vagus nerves in bursts in conscious calves.

T E Adrian, S R Bloom, A V Edwards.   

Abstract

Effects of stimulation of the peripheral ends of the vagus nerves below the heart at 4 Hz continuously, and at 40 Hz for 1 s at 10 s intervals, have been compared in conscious calves below behavioural threshold. Neither pattern of stimulation caused any significant change in mean aortic blood pressure or heart rate but both invariably produced a substantial increase in the flow of intestinal lymph. Each form of stimulation provoked release of glucagon, insulin and pancreatic polypeptide from the pancreas and produced a small but significant rise in mean arterial plasma glucose concentration. The release of gastric inhibitory peptide- and bombesin-like molecules from the gastrointestinal tract was not affected by vagal stimulation whereas release of vasoactive intestinal peptide was observed in response to both patterns of vagal stimulation. Evidence was obtained to suggest that gastrin-like peptides are preferentially released into the bloodstream whereas cholecystokinin-like peptides are not. Vagal stimulation releases somatostatin from the gastrointestinal tract but discontinuous stimulation seems to inhibit the release of somatostatin into the general circulation. The results that have been obtained, employing this particular protocol, suggest that the pattern of the stimulus that is applied to the vagal splanchnic innervation has relatively little effect on neuroendocrine response in this species.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6361233      PMCID: PMC1193822          DOI: 10.1113/jphysiol.1983.sp014921

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  33 in total

1.  Vagal release of somatostatin into the antral lumen of cats.

Authors:  K Uvnäs-Wallensten; S Efendic; R Luft
Journal:  Acta Physiol Scand       Date:  1977-01

Review 2.  Gastrin (first of two parts).

Authors:  J H Walsh; M I Grossman
Journal:  N Engl J Med       Date:  1975-06-19       Impact factor: 91.245

3.  Structure-function and structure-immunoreactivity relationships of the glucagon molecule and related synthetic peptides.

Authors:  R Assan; N Slusher
Journal:  Diabetes       Date:  1972-08       Impact factor: 9.461

4.  A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties.

Authors:  J D Albano; R P Ekins; G Maritz; R C Turner
Journal:  Acta Endocrinol (Copenh)       Date:  1972-07

5.  The occurrence of somatostatin-like immunoreactivity in the vagal nerves.

Authors:  K Uvnäs-Wallensten; S Efendić; R Luft
Journal:  Acta Physiol Scand       Date:  1978-02

6.  Human pancreatic polypeptide and vasoactive intestinal polypeptide.

Authors:  L I Larsson
Journal:  Lancet       Date:  1976-08-28       Impact factor: 79.321

7.  Measurement of fasting and postprandial plasma VIP in man.

Authors:  S J Mitchell; S R Bloom
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

8.  Changes in the concentration of vasoactive intestinal peptide in intestinal lymph in response to vagal stimulation in the calf.

Authors:  A V Edwards; P M Birchman; S J Mitchell; S R Bloom
Journal:  Experientia       Date:  1978-09-15

9.  Distribution and release of human pancreatic polypeptide.

Authors:  T E Adrian; S R Bloom; M G Bryant; J M Polak; P H Heitz; A J Barnes
Journal:  Gut       Date:  1976-12       Impact factor: 23.059

10.  Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract.

Authors:  J Fahrenkrug; H Galbo; J J Holst; O B Schaffalitzky de Muckadell
Journal:  J Physiol       Date:  1978-07       Impact factor: 5.182

View more
  9 in total

Review 1.  Designing a bioelectronic treatment for Type 1 diabetes: targeted parasympathetic modulation of insulin secretion.

Authors:  Elliott W Dirr; Morgan E Urdaneta; Yogi Patel; Richard D Johnson; Martha Campbell-Thompson; Kevin J Otto
Journal:  Bioelectron Med (Lond)       Date:  2020-07-28

2.  Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.

Authors:  L O Uttenthal; O O Ukponmwan; M Ghiglione; S R Bloom
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

3.  Effects of certain metabolites on pancreatic endocrine responses to stimulation of the vagus nerves in conscious calves.

Authors:  S R Bloom; A V Edwards
Journal:  J Physiol       Date:  1985-05       Impact factor: 5.182

4.  Characteristics of the neuroendocrine responses to stimulation of the splanchnic nerves in bursts in the conscious calf.

Authors:  S R Bloom; A V Edwards
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

5.  Neuroendocrine responses to stimulation of the splanchnic nerves in bursts in the conscious adrenalectomized calf.

Authors:  S R Bloom; A V Edwards; M A Ghatei
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

6.  Effects of certain metabolites on pancreatic endocrine responses to gastrin-releasing peptide in conscious calves.

Authors:  S R Bloom; A V Edwards; M A Ghatei
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

7.  Release of vasodilator, but not vasoconstrictor, neuropeptides and of enteroglucagon by intestinal ischaemia/reperfusion in the rat.

Authors:  L Meleagros; M A Ghatei; S R Bloom
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

8.  Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans.

Authors:  Marzieh Salehi; Ronald L Prigeon; David A D'Alessio
Journal:  Diabetes       Date:  2011-09       Impact factor: 9.461

9.  Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients.

Authors:  Stefania Camastra; Elza Muscelli; Amalia Gastaldelli; Jens J Holst; Brenno Astiarraga; Simona Baldi; Monica Nannipieri; Demetrio Ciociaro; Marco Anselmino; Andrea Mari; Ele Ferrannini
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.